Categories
News

Sweden’s Economy, After Not Having Lockdown, in Much Better Shape Than Rest of Europe – Newsweek

  • Sweden’s GDP fell 8.6 in Q2 2020, the country’s worst quarterly decline in modern history.
  • The Scandanavian nation markedly outperformed the rest of Europe. Its GDP drop in the second quarter was lower than the 12.1 average experienced in the Eurozone, as well as the 11.9 average across the whole of the EU.
  • Sweden outperformed several European countries, including Spain (18.5 percent fall), France (13.6 percent), Italy (12.4 percent) and Germany (10.1 percent).

https://www.newsweek.com/coronavirus-sweden-economy-gross-domestic-product-eurozone-better-europe-1523359

Categories
Opinion

Bring on Britain’s corona clowns – The Spectator

The Recovery trial has steadfastly ignored Professor Didier Raoult and a string of countries that have implemented his protocol, early use of HCQ with Azythromycin in safe doses, despite the fact that, after treating 3,737 patients — the single largest study in the world —Raoult has lost only 0.6 per cent, while Horby and Landray are presiding over carnage —a fatality rate of 25 per cent.

  • The Recovery trial has steadfastly ignored Professor Didier Raoult in the early use of HCQ with Azythromycin in safe doses.
  • Raoult has lost only 0.6 per cent, while Horby and Landray are presiding over carnage —a fatality rate of 25 per cent.
  • Landray admitted to an investigative journalist at FranceSoir ‘these are quite high doses to… have a chance of killing the virus.’ Or killing the patient.
  • Recovery is not the only trial delivering dangerously elevated doses of HCQ to Covid patients. Dosage in the international Solidarity trial was four times greater than the dose being used in India.
  • WHO has been working for years with Gilead Sciences trying to get the pharmaceutical company’s lacklustre drug Remdesivir to show efficacy at curing first Ebola, with poor results, and now Covid-19.
  • Landray revealed Gilead pays scientists 20 to 50 times more to conduct a clinical trial than Horby and Landray were paid to conduct the Recovery trial.
  • Horby is the executive director of the International Severe Acute Respiratory and Emerging Infection Consortium which received 4.5 million pounds for research into vaccines.
  • Horby established the Epidemic Research Group which is promised up to 14 million pounds from AstraZeneca and Zuckerberg/Chan of Facebook fame for the development of a Covid-19 vaccine which is being trialled by Oxford University.
  • AstraZeneca is interested in merging with Gilead Sciences, which, if it went through, would create the biggest Big Pharma ever.
  • Horby and Landray have announced that dexamethasone, a low-cost steroid which is also being tested has reduced the mortality rate of Covid-19 patients on ventilators from a scandalous 41 per cent to a still appalling 32 per cent.
  • Raoult has pointed out that in his hospital, of the 0.6 per cent who die, a mere 16 per cent were in ICU
  • In Britain, where almost 42,000 people have died of Covid, the only thing randomised, controlled trials have achieved, is to blind people to the evidence that 40,000 of those deaths could have been avoided.

https://www.spectator.com.au/2020/06/bring-on-britains-corona-clowns/p>

Categories
News

Colmar: des traces du coronavirus détectées sur un scanner dès le 16 novembre – Le Figaro

Radiologists at the Albert Schweitzer hospital in Colmar have detected traces of COVID-19 since November 2019.

https://www.lefigaro.fr/sciences/colmar-des-traces-du-coronavirus-detectees-sur-un-scanner-des-le-16-novembre-20200519

English article on the same topic:

http://www.rfi.fr/en/france/20200520-scans-show-french-patients-were-sick-with-covid-19-in-mid-november-doctors-say-colmar-haut-rhin

Categories
Publications

The rate of positive tests in the US, France, Germany and Switzerland is not increasing exponentially

The rate of positive tests in the US, France, Germany and Switzerland is not increasing exponentially.

Felix Scholkmann is a biophysicist at University Hospital Zurich, University of Zurich, Switzerland.

Categories
Publications

SARS-CoV-2: fear versus data

“The mortality rate for SARS-CoV-2 is not significantly different from that for common coronaviruses identified at the study hospital in France”.

https://www.sciencedirect.com/science/article/pii/S0924857920300972